首页> 外文期刊>Anticancer Research: International Journal of Cancer Research and Treatment >CTNNB1 Mutations in Ovarian Microcystic Stromal Tumors: Identification of a Novel Deletion Mutation and the Use of Pyrosequencing to Identify Reported Point Mutation
【24h】

CTNNB1 Mutations in Ovarian Microcystic Stromal Tumors: Identification of a Novel Deletion Mutation and the Use of Pyrosequencing to Identify Reported Point Mutation

机译:CTNNB1在卵巢微阴囊基质肿瘤中的突变:鉴定新型缺失突变和焦磷酸的使用以鉴定报告的点突变

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Background/Aim: Microcystic stromal tumor (MCST) is a rare stromal tumor of the ovary. In this study, we describe clinicopathological characteristics and results of mutational analyses of the CTNNB1gene in two cases of ovarian MCST and we provide a thorough review of previously published cases alongside our current cases and clarify the clinicopathological characteristics of ovarian MCST. Patients and Methods: Patients' age was 33 and 31 years, respectively. One patient presented with fever and low abdominal pain, whereas a pelvic mass was incidentally detected in another patient. Grossly, the cut surface of the tumors was mixed solid and cystic. Results: Histologically, the tumor characteristically displayed numerous microcysts, solid cellular areas, and intervening hyalinized stroma. Areas of moderate-to-severe nuclear pleomorphism with occasional multinucleated giant cells and bizarre nuclei were noted in one of the two cases. Immunohistochemically, both cases demonstrated diffuse and strong beta-catenin expression in the nuclei and the cytoplasm. The tumor cells were also diffusely positive for CD10, vimentin, Wilms tumor 1, and cyclin D1. The tumor cells were consistently negative for E-cadherin, inhibin-a, calretinin, estrogen receptor, and progesterone receptor. Mutational analyses using direct sequencing and pyrosequencing methods exhibited a single nucleotide mutation in CTNNB1 exon 3 (c.122C>T) in one case. We also found a novel deletion mutation in the same exon (c.88_99delTACCTGGACTCT) in another case. Conclusion: We demonstrated a previously reported CTNNB1 point-mutation using pyrosequencing and a novel deletion mutation in ovarian MCSTs. The review of the literature of previously published cases in combination with our current cases clarifies the clinicopathological characteristics of ovarian MCST and the comprehensive analysis of these cases would expand our knowledge regarding ovarian MCST.
机译:背景/目的:微囊体基质肿瘤(MCST)是卵巢的罕见基质肿瘤。在这项研究中,我们描述了两种卵巢MCST中CTNNB1庚烯的临床病理特征和突变分析结果,我们对先前公布的病例提供了彻底的审查,并阐明了卵巢MCST的临床病理特征。患者和方法:患者年龄分别为33和31岁。一名患者患有发烧和低腹痛,而盆腔肿块偶然检测到另一名患者。总,肿瘤的切割表面混合固体和囊性。结果:组织学上,肿瘤特征性地展示了多种微囊体,固体细胞区域和干扰透明的基质。两种情况下,注意到与偶尔多核巨细胞和奇异核的中度至严重的核渗透区域。免疫组织化学,这两种情况都证明了核和细胞质中的弥漫性和强β-连环蛋白表达。肿瘤细胞也弥漫性阳性CD10,Vimentin,Wilms肿瘤1和细胞周期蛋白D1。肿瘤细胞始终是对e-cadherin,抑制蛋白-a,calretinin,雌激素受体和孕酮受体的负阴性。使用直接测序和焦磷酸测序方法的突变分析在一种情况下表现出CTNNB1外显子3(C.122C> T)中的单核苷酸突变。我们还在另一个案例中发现了同一外显子(C.88_99Deltacctctct)的新型缺失突变。结论:我们证明了先前报道的CTNNB1点突变使用焦磷酸盐和卵巢MCST的新缺失突变。审查与我们目前的病例组合的先前公布病例的文献阐明了卵巢MCST的临床病理特征,对这些案件的综合分析将扩大关于卵巢MCST的知识。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号